OncoSec Medical Incorporated
ONCSQ
$0.00
$0.000.00%
OTC PK
| 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.88M | 10.46M | 11.19M | 14.46M | 14.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.65M | 34.40M | 37.01M | 42.76M | 43.65M |
| Operating Income | -32.65M | -34.40M | -37.01M | -42.76M | -43.65M |
| Income Before Tax | -32.72M | -35.77M | -37.51M | -43.51M | -43.37M |
| Income Tax Expenses | -3.33M | -3.33M | -3.33M | -5.75M | -2.41M |
| Earnings from Continuing Operations | -29.39 | -32.43 | -34.18 | -37.76 | -40.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.39M | -32.43M | -34.18M | -37.76M | -40.95M |
| EBIT | -32.65M | -34.40M | -37.01M | -42.76M | -43.65M |
| EBITDA | -32.40M | -34.15M | -36.75M | -42.50M | -43.39M |
| EPS Basic | -15.24 | -18.13 | -19.14 | -21.19 | -23.26 |
| Normalized Basic EPS | -10.69 | -12.50 | -13.12 | -15.26 | -15.74 |
| EPS Diluted | -15.24 | -18.13 | -19.14 | -21.19 | -23.26 |
| Normalized Diluted EPS | -10.69 | -12.50 | -13.12 | -15.26 | -15.74 |
| Average Basic Shares Outstanding | 7.96M | 7.16M | 7.15M | 7.13M | 7.04M |
| Average Diluted Shares Outstanding | 7.96M | 7.16M | 7.15M | 7.13M | 7.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |